STRATEC Biomedical AG announced the appointment of Dr. Claus Vielsack to the Board of Management of the company as Product Development Director, effective February 15, 2014. Dr. Vielsack expands the current Board of Management, comprising Marcus Wolfinger, Dr. Robert Siegle and Bernd M. Steidle, and will be responsible for the group-wide management of product development, an area for which he has borne responsibility since 2011 in his capacity as Senior Vice President. Dr. Vielsack has held various senior product development positions at the company since 1998.

Before joining the company, he held a number of different positions working as a program manager in the development of chemical applications and software solutions.